Editorial: Entering the RNA Wonderland: Opportunities and Challenges for RNA Therapeutics in the Cardiovascular System

Anna Zampetaki*, Lars Maegdefessel

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Article number60
JournalFrontiers in Physiology
Volume11
DOIs
Publication statusPublished - 7 Feb 2020

Keywords

  • cardiovascular diseases
  • gene editing
  • non-coding RNA
  • RNA structure
  • RNA therapeutics

Cite this